Cerenome, Inc. (CNSY)
NASDAQ: CNSY · Real-Time Price · USD
2.755
-0.225 (-7.55%)
At close: Sep 4, 2026, 4:00 PM EDT
2.852
+0.097 (3.52%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Cerenome Market Cap
Cerenome has a market cap or net worth of $20.91 million as of September 4, 2026. Its market cap has decreased by -54.25% in one year.
Market Cap
20.91M
Enterprise Value
12.37M
1-Year Change
-54.25%
Ranking
Category
Stock Price
$2.76
ChartMarket Cap Chart
Since March 30, 2001, Cerenome's market cap has decreased from $80.80M to $20.91M, a decrease of -74.12%. That is a compound annual growth rate of -5.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 20.91M | -70.17% |
| Dec 31, 2025 | 70.10M | 930.88% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -26.17% |
| Dec 30, 2022 | 10.70M | -33.54% |
| Dec 31, 2021 | 16.10M | 65.98% |
| Dec 31, 2020 | 9.70M | 7.78% |
| Dec 31, 2019 | 9.00M | 136.84% |
| Dec 31, 2018 | 3.80M | -64.15% |
| Dec 29, 2017 | 10.60M | -65.58% |
| Dec 30, 2016 | 30.80M | 5.84% |
| Dec 31, 2015 | 29.10M | -35.76% |
| Dec 31, 2014 | 45.30M | -73.86% |
| Dec 31, 2013 | 173.30M | 4.90% |
| Dec 31, 2012 | 165.20M | 33.66% |
| Dec 30, 2011 | 123.60M | -52.91% |
| Dec 31, 2010 | 262.50M | 9.42% |
| Dec 31, 2009 | 239.90M | 136.59% |
| Dec 31, 2008 | 101.40M | -33.73% |
| Dec 31, 2007 | 153.00M | 18.97% |
| Dec 29, 2006 | 128.60M | 10.29% |
| Dec 30, 2005 | 116.60M | 202.07% |
| Dec 31, 2004 | 38.60M | -9.81% |
| Dec 31, 2003 | 42.80M | -23.84% |
| Dec 31, 2002 | 56.20M | 24.89% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 22.40M |
| Akari Therapeutics, | 22.33M |
| Cocrystal Pharma | 21.77M |
| Longeveron | 21.71M |
| Polyrizon | 21.04M |
| Neuphoria Therapeutics | 20.38M |
| Lipocine | 20.20M |
| Marker Therapeutics | 19.67M |